Recommended Global Biochemistry Conferences
Metabolomics Meeting 2017
ConferenceSeries Ltd 10th International Conference and Exhibition on Metabolomics & Systems Biology during October 19-20, 2017 Baltimore, USA. This is a fabulous open door for the representatives from Universities and Institutes to communicate with the world class Scientists.
Metabolomics Meeting 2017 Conference will be an investigation of New research Innovation of Metabolomics and spread the most recent advancements and patterns in Metabolomics displaying, Proteomics, Systems Biology, Genomics, Precision Medicine, Lipidomics, LC-MS and GC-MS Techniques, Bioinformatics, Plant Metabolomics, Clinical metabolomics, tumor and digestion system, computational science, metabolomics disorder, Nutritional Metabolomics, Therapeutic Metabolomics and more. Metabolomics is of enthusiasm to doctors in light of the fact that it might prompt enhancements in the conclusion and medications of human illnesses. Metabolomics as an order makes utilization of systematic procedures, for example, spectroscopy, chromatography, and multivariable investigation. Metabolomics permits researchers to gauge physiological impacts and to screen for unfavorable responses to tranquilizes.
Theme: Metabolomics, a promising approach to Cancer, Cardiovascular disease and immunology
Track 1 : Cancer Therapeutic Approaches
Cancer biomarkers have expanded immensely giving extraordinary chances to enhancing so as to enhance the administration of disease patients the proficiency of discovery and viability of treatment. Late innovative headway has empowered the examination of numerous potential biomarkers and recharged enthusiasm for growing new biomarkers. Biomarkers of disease could incorporate a wide scope of biochemical elements, for example, nucleic acids, proteins, sugars, lipids, and little metabolites, cytogenetic and cytokinetic parameters and additionally entire tumor cells found in the body liquid. A far reaching comprehension of the pertinence of each biomarker will be vital for diagnosing the illness dependably, as well as help in the decision of different remedial options as of now accessible that is prone to advantage the patients. A biological molecule found in blood, other body liquids, or tissues that is an indication of a typical or strange procedure, or of a condition or sickness. A biomarker might be utilized to perceive how well the body reacts to a treatment for a sickness or condition. Also called molecular marker and signature molecule.
Track 2 : Metabolic Syndrome
Metabolomic profiling has been used to recognize novel biomarkers and instruments of cardiovascular malady hazard. Support and Metabolism Center and Center for Human Genetics at Duke University where the examination is proceeding with National Institutes of Health grants .Metabolomics can give certain inclinations in admiration to other "omics" progressions in diabetes research. CEDAM (Center for Endocrinology, Diabetes and Metabolism) investigation is centered around a seat to-bedside approach, taking examination through from essential science exposure to clinical application. Metabolomic approach gives novel encounters into the robotic investigations of antitumor prescriptions from a point specific from customary pharmaceutical examinations. Metabolic profiling is the multiparallel relative evaluation of a blend of mixes or compound classes utilizing chromatography and all inclusive discovery advancements (GC-MS, LCMS). Metabolic profiling can supplement routine frameworks and other "omics" propels in inquiring about preclinical prescription change issues.
Track 3 : Metabolomics in Precision Medicine
Precision medicine is an approach to manage finding and making solutions and antibodies that passes on unrivaled results for patients, by fusing clinical and sub-nuclear information to fathom the natural reason of infection. Pharmacometabolomics illuminates and compliments pharmacogenomics and together they give building pieces to Quantitative and Systems Pharmacology. Precision medicine is a rising methodology for illness treatment and avoidance that considers singular variability in qualities, environment, and way of life for every individual. While a few advances in exactness prescription have been made, the practice is not as of now being used for most diseases. Accuracy offers cutting edge answers for augment your achievement in translational examination. The appearance of monstrous parallel sequencing is dependable of an outlook change in biomarker disclosure and clinical trial plan while in transit to what is currently called "biomarker-driven disease solution" or "accuracy pharmaceutical."
Track 4 : Frontiers of Metabolomics Research
Metabolomic studies can incite enhanced cognizance of disease instruments and to new indicative markers furthermore redesigned perception of medication for solution or xenobiotic impact and expanded capacity to anticipate singular variety in medication reaction phenotypes. Howard University Center for Computational Biology and Bioinformatics (CCBB) is to empower and propel the use of computational approaches to manage the examination of biomedical and disease frames. New programming and progressively complex NMR metabolitespectral databases are impelling the fascinating limits of NMR spectroscopy to perceive and assess little particles in answer for examinations of metabolite biomarkers and metabolic flux. MS appreciates a solid point of interest in affectability contrasted and NMR and, through utilization of various blends of chromatographic techniques and mass/charge partition innovations, gives the capacity to gauge a more extensive cluster of little particle metabolites.
Track 5 : Therapeutic Metabolomics
The role of metabolism in invulnerability has been underexplored along these lines, yet then researchers have made basic duties in depicting relationship of safe methods and metabolic pathways. Frameworks immunology means to think about the invulnerable framework in the more coordinated viewpoint on how elements and players take part at various framework levels to the safe function. Computational immunology is a field of science that incorporates high-throughput genomic and bioinformatics ways to deal with immunology.
Track 6 : Transcriptomics & Metabolic pathways
Transcriptomics is worried with deciding how the transcriptome, and subsequently example of quality expression, changes regarding different components, for example, kind of tissue, phase of advancement, hormones, medications, or ailment. It supplements and covers with proteomics. Metabolic pathway is a progression of concoction responses happening inside of a cell. In a pathway, the beginning compound (metabolite) is changed by an arrangement of synthetic responses. These responses are catalyzed by catalysts, where the result of one compound goes about as the substrate for the following. These chemicals frequently require dietary minerals, vitamins, and different cofactors to work.
Track 7 : Metabolic Modelling
Metabolomic profiling is frequently performed with either Nuclear magnetic resonance (NMR) or MS. Individual analytes inside of the specimen are isolated by their attractive reverberation move or mass-to-charge proportion, separately, bringing about an otherworldly profile of partition. At the point when working with natural liquids, NMR regularly does not require substance control of an example, though MS for the most part requires derivatization of metabolites to create ionic species that are all the more promptly isolated by the mass-to-charge proportion. Metabolism is an essential cell procedure, and its glitch can be a noteworthy donor to numerous human sicknesses. Metabolites can serve as a metabolic ailment biomarker. Recognition of such biomarkers assumes a huge part in the investigation of biochemical response and flagging systems.
Track 8 : Clinical Metabolomics & Lipidomics
Metabolomics and lipidomics, extreme mechanical assemblies in systems science, hope to screen little metabolites present in natural illustrations. Contrasts in the species or measures of metabolites can be used to depict phenotypes and common responses to inconveniences. Translational Biomarker Discovery Core fuse recognizing, supporting and making pre-clinical biomarkers for working up the region of illness, observing reduction status, choosing the practicality of specific therapeutic traditions, and controlling the decision of specific accommodating interventions. Biomarkers of ailment could consolidate a wide extent of biochemical components, for instance, nucleic acids, proteins, sugars, lipids, and little metabolites, cytogenetic and cytokinetic parameters and moreover whole tumor cells found in the body fluid. An extensive perception of the relevance of each biomarker will be basic for diagnosing the ailment constantly, and also help in the choice of various healing choices starting now open that is inclined to advantage the patients.
Track 9 : Plant & Environmental Metabolomics
Metabolomics is the examination of endogenous and exogenous low atomic mass metabolites inside of a cell, tissue, or biofluid of a life form in light of an outer stressor. The sub-control of environmental metabolomics is the utilization of metabolomic strategies to investigate the connections of life forms with their surroundings. Drug metabolism system is the procedure by which the body separates and changes over pharmaceutical into dynamic concoction substances. Toxicology is a branch of Medical Science that arrangements with the impacts of synthetic compound utilized as a part of the conclusion, treatment, or counteractive action of ailment or other unusual condition on the body. Plant Metabolomics is to contemplate the plant framework at the sub-atomic level giving non-one-sided characterization of the total metabolite pool (metabolome) of plants under particular conditions. Using Metabolomics, a better understanding of the correlation between genes and the biochemical composition of a plant tissue in response to its environment (phenotype) can be obtained, and this information can be further used to assess gene function (genotype). Four joint U.S. also, Japanese research groups have been recompensed subsidizing totaling about $12 million (about Yen 960 million) to grow new naturally well disposed strategies to expand the creation of renewable biofuel and lessen pesticide use.
Track 10 : Food & Nutritional Metabolomics
Unlike other ‘omics’ technologies (genomics, proteomics…etc), metabolomics gives organic understanding that mirrors an individual's one of a kind hereditary unique mark, as well as way of life, eating routine and environment. Utilizing metabolomics, scientists can quantitatively dissect non-hereditary variables that are included in postgenomic and posttranscriptional change. Nutritional metabolomics is quickly developing to utilize little atom substance profiling to bolster incorporation of eating regimen and sustenance in complex biosystems research. Nutrigenomics is a branch of nutritional genomics and is the study of the effects of foods and food constituents on gene expression. Foodomics has been recently defined as a new discipline that studies food and nutrition domains through the application of advanced omics technologies in which MS techniques are considered indispensable. Applications of Foodomics include the genomic, transcriptomic, proteomic, and/or metabolomic study of foods for compound profiling, authenticity, and/or biomarker-detection related to food quality or safety; the development of new transgenic foods, food contaminants, and whole toxicity studies; new investigations on food bioactivity, food effects on human health. The University of Michigan Nutrition Obesity Research Center (UM NORC) started in 2010, supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The UM NORC is one of 12 U.S. focuses intended to move and backing translational, multi-disciplinary exploration in heftiness and sustenance, over the continuum of fundamental science to applications in people (solution) and populations (public health).
Track 11: Metabolomic devices
Metabolomics, alternately metabonomics, a rising field of biochemical exploration, is a reciprocal procedure to genomics, transcriptomics, and proteomics. Direct quantitative estimations of metabolite expressions in pee, serum, plasma, and tissue are crucial for the investigation of organic procedures in typical and illness states. Subsequent to the quantity of metabolites in a natural example is extensive partition science assumes an imperative part in metabolomic research. Atomic attractive reverberation (NMR) spectroscopy is especially capable for focused investigation since it is quantitative, reproducible, and suitable for complex examples, for example, blood, pee, or tissue removes with practically zero preparing. Thermo Fisher, AB SCIEX, and Bruker likewise offer instruments for imaging MS, additionally called MALDI imaging. To meet difficulties of searchability and information reconciliation, the metabolomics group has a few activities to build up information vaults. Cases are Metabolights in the United Kingdom, bolstered by the European COSMOS (COordination of Standards in MetabOlomicS) consortium that is creating metabolomics information norms, and Metabolomics Workbench, which means to be the database for NIH-subsidized metabolomics ventures. Thermo Fisher teams up with Fiehn on mzcloud.org, a free community database that includes actual and virtual MS spectra with unknown compounds to be annotated as they are identified.
Track 12 : Analytical Platforms in Metabolomics
In metabolomics, real endeavors are put resources into the advancement of suitable scientific methodologies. Metabolomics, the most youngest field in the 'omics family, is growing rapidly. Developing directly behind genomics, transcriptomics, and proteomics, metabolomics is the extensive examination of little particle metabolites. Subsequent to most metabolites are produced by enzymatic proteins that outcome from quality expression, and metabolites give creatures their biochemical attributes, the metabolome links genotype with phenotype. Metabolomics is as yet growing, however, as merchants adjust division and discovery instruments to meet its difficulties and the examination group deciphers and incorporates the mind boggling information they are gaining. The late quick advancement of a scope of investigative stages, including GC, HPLC, UPLC, CE coupled to MS and NMR spectroscopy, could empower partition, identification, portrayal and evaluation of such metabolites and related metabolic pathways. Proceeded with improvement of these diagnostic stages will quicken far reaching use and coordination of metabolomics into frameworks science. NIH Awards $1.6M to Fund microRNA Biomarker Research in Cancer, Alzheimer's Disease . The Bill and Melinda Gates Foundation today declared $7.7 million in financing for 10 new grants to identify biomarkers for diagnosing tuberculosis (TB) in low-resource settings.
Track 13 : Data Analysis & Systems Biology
Systems biology is a field within biology aimed at understanding biological processes at the systems level and emerging from dynamic interactions of individual components operating at multiple spatiotemporal scales. Systems biology considers organic Systems by efficiently bothering them (organically, hereditarily, or artificially); observing the quality, protein, and educational pathway reactions; incorporating these information; eventually, planning numerical models that portray the structure of the framework and anticipate its reaction to individual irritations. Integrated “omics” approaches have made energizing open doors for Systems science and other organic examines. Decreases in the expense of producing genomic information have made DNA sequencing, RNA-seq, and high-throughput screening an undeniably imperative piece of biomedical exploration. The National Institute of General Medicine Sciences (NIGMS), an organization of the National Institutes of Health (NIH) supporting fundamental research and research preparing, declared not long ago that it would build up two new divisions — including one concentrated on biomedical innovation, bioinformatics, and computational biology – – as part of a reorganization that includes the dissolution of the NIH National Center for Research Resources (NCRR) which has had a history of supporting scientific computing.
Track 14 : Enhancing Analytical Approaches
The rapidly growing area of "metabolomics," in which an extensive number of metabolites from body liquids, cells or tissue are identified quantitatively, in a solitary step, guarantees colossal potential for various orders including early infection conclusion, treatment checking, systems biology,drug discovery and nutritional science. In light of its capacity to distinguish countless in place organic specimens reproducibly and quantitatively, nuclear magnetic resonance (NMR) spectroscopy has risen as a standout amongst the most intense diagnostic systems in metabolomics. Metabolon, Aglient Technologies, Thermo Scientific, Chenomx and Human Metabolome Technologies, Biocrates Life Sciences, and Metanomics are the main leaders in the metabolomics space. They are dynamic in numerous parts of this business sector: diagnostics item improvement, profiling administrations, scholarly joint efforts, and even acquisitions. Through the NIH Common Fund's Increasing Metabolomics Research Capacity program External Web Site Policy, the NIH has conferred more than $65 million to quicken the field of metabolomics throughout the following five years. The objective of this financing project is to propel a few center regions, including thorough metabolomics asset centers, metabolomics innovation improvement, metabolomics reference gauges combination, and preparing and instructive exercises in metabolomics.
Track 15 : Case Reports
Case reports are a vital direct wellspring of confirmation in pharmaceutical and a device regularly utilized as a part of practice to trade data and create a more extended quest for proof. A decent case report will be clear about the significance of the perception being accounted for. A good case report will be clear about the importance of the observation being reported. In addition to the “evidence of what happened”, single or multiple cases are an important basis for further and more advanced research on diagnosis, treatment adequacy, reasons and results of ailment. Case reports might be first to give signs in distinguishing another ailment or unfriendly wellbeing impact from a presentation. Case reports must be authentic, understandable, educational and clinically interesting to an international audience of surgeons, trainees and researchers in all surgical subspecialties, as well as clinicians in related fields.
ConferenceSeries Ltd welcomes you to attend the 10th International Conference and Exhibition on Metabolomics & Systems Biology during October 19-20, 2017 Baltimore, USA. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. The main theme of the conference is “Metabolomics, a promising approach to Cancer, Cardiovascular disease and immunology”.
Metabolomics Meeting 2017 Conference will be an exploration of New research Innovation of Metabolomics and cover the latest developments and trends in Metabolomics modeling, Proteomics, Systems Biology, Genomics, Precision Medicine, Lipidomics, LC-MS and GC-MS Techniques, Bioinformatics, Plant Metabolomics, Clinical metabolomics, cancer and metabolism, computational biology, metabolomics syndrome, Nutritional Metabolomics, Therapeutic Metabolomics and more. Metabolomics is of interest to physicians because it may lead to improvements in the diagnosis and treatments of human diseases. ConferenceSeries Ltd Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide. The global metabolomics market is expected to grow at a strong CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $2,100 million by 2019. The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing.
Market Analysis Report
Metabolomics is an emerging field which combines strategies to identify and quantify cellular metabolites using sophisticated analytical technologies with the application of statistical and multi-variant methods for information extraction and data interpretation. Metabolomics is the study of small metabolites. Metabolomics Conference deals with topics like Bioinformatics, proteomics, systems biology, Analytical Techniques like NMR, GC-MS, LC-MS and CE-MS, Lipidomics, Metabolic Modelling, Metabolic profiling, clinical metabolomics, Translational sciences, Mass spectrometry, Metabolomics Syndrome, HPLC and CE based metabolomics and more. Metabolomics - the new "omics" - is a dynamic and developing field, joining genomics, transcriptomics and proteomics in empowering an integrative frameworks science methodology to drug discovery and development. In spite of the fact that metabolomics is still at an early evolutionary stage it is conjecture that throughout the following decade the biopharma business will apply this innovation all the more generally in drug development and information.
'The Future of Metabolomics' gives fully fledged understanding into the compelling utilization of metabolomics all through drug discovery, preclinical development and clinical trials. The report also highlights the use of metabolomics in maximizing and sustaining revenues post-marketing and in the development of clinical diagnostics.
Importance & Scope:
Metabolomics is now being extensively used in pharmaceutical and biotechnology industries for biomarker and drug discovery; pharmaceutical and biotechnology industries are expected to grow at a high rate in coming years, which is expected to boost the growth of the market.
The National Institutes of Health said that they are to invest $14.3 million for metabolomics research, potentially investing more than $51.4 million over five years, to accelerate an emerging field of biomedical research known as metabolomics. As per National Center for Biotechnology Information. Metabolomics has matured over the past 10 years. Over 300 studies have been completed over the past 5 years.
Global Life Science Market Share by Country
Why to attend ???
Meet Your Target Market With recent business reports on Metabolomics making news which manifests the tremendous growth in market value for metabolomics technology till 2019. Since metabolomics interrelated with omics sciences like Genomics, precision Medicine, Proteomics, Lipidomics, Fluxomics and Transcriptomics, it would be a great opportunity for companies dealing with Analytical instruments useful in these fields. Also many upcoming students and researchers can benefit themselves by participating world class International workshops, symposia during the conference which will be conducted by experts in the respective fields.
Major Metabolomics Related Associations around the Globe :
American association for the advancement of science
American association for clinical chemistry
American association for cancer research
American association of pharmaceutical scientists
Association for Consumer Research (ACR)
American cancer society
Bioinformatics society of India
The British Society for Genetic Medicine
The Genetics Society
Netherlands metabolomics center
The Australian biotechnology association
Human Proteome Organization
Indiana Proteomics Consortium
European federation of biotechnology
Australasian Proteomics Society
Clinical Genetics Society
Directors/Managers & Business Delegates, Director of Laboratories, Universities, Industries, Investigators, Post Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies.
Rise in the number of clinical trials, toxicological studies, and health awareness for nutritional products, rapid growth of metabolomics data analysis software and solutions, and use of metabolomics as diagnostics tool for biomarker screening of diseases is expected to propel the growth of this market.
Glance at Market of Metabolomics:
The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibits the growth of the metabolomics market to a certain extent. Metabolomics science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the metabolomics market.
In 2013, North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.
The global metabolomics market was valued at $565 million in 2014 and is expected to grow at a CAGR of 30% from 2014 to 2019.
Statistics which shows growth in importance of Metabolomics :
Metabolomics Market Worth $2,100 Million by 2019 - New Report by Markets and Markets.
Statistics of Industries Associated with Metabolomics :
North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.
The major players in the metabolomics market include Thermo Fisher Scientific (U.S.), Metabolon, Inc. (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.), Agilent Technologies (U.S.), and Bruker Corporation (U.S.).
Fund Allotment towards Metabolomics Research :
The National Institutes of Health has provided tens of millions of dollars in new funding to support three new Comprehensive Metabolomics Centers at Mayo Clinic, the University of Kentucky, and the University of Florida.
These three centers will receive an estimated $9 million to $10 million each over the next five years to create resources and initiate research programs that will ramp up the national metabolomics science capabilities.
NIH provided $14.3 million to fund the launch of three other metabolomics resource centers at the University of Michigan, the Research Triangle Institute, and the University of California, USA
- Michigan Regional Comprehensive Metabolomics Resource Core (MRC2)
- NIH West Coast Metabolomics Center at UC Davis
- Southeast Center for Integrated Metabolomics (SECIM)
- Metabolomics Core at Mayo Clinic
- Research Center for Stable Isotope Resolved Metabolomics
Funding to UC San Diego for this project is $6 million over five years, part of a total investment by the NIH of $51.4 for the metabolomics project. The awards are supported by the NIH Common Fund.
Metabolomic Diagnostics is engaged in a study called IMPROVED, which has received €6m in European FP7 funding.
Mayo Clinic is one of six new federally-funded Comprehensive Metabolomics centres to support medical research on metabolomics — the study, at the cellular level, of how molecules are metabolized in the body. The award from the National Institutes of Health (NIH) is for $8.8 million over five years.
Past Conference Report
Metabolomics Meeting 2016
Metabolomics Meeting 2016 Report
The 7th International Conference and Expo on Metabolomics, Metabolomics Meeting 2016 was held in Orlando, Florida, USA, during November 14-16, 2016.
Metabolomics Meeting 2016 has welcomed the new era of Metabolomics; a futuristic arena for treatment of diseases, clasping a promising tomorrow. The highly exalted conference hosted by Conference Series LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 10 countries around the world. The conference has tried grounding every aspect related to Metabolomics and Cancer, covering all the possible research areas and crux.
The conference aimed a parallel rail with theme “Ground Breaking Analytical Concepts and Computational Methods”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Metabolomics and Cancer Research, Analytical Techniques in Metabolomics, Applications of Separation Sciences in Metabolomics, Frontiers of Metabolomics Research, Systems biology and Computational Biology, Bioinformatics and Advancements, Clinical Metabolomics and Lipidomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Metabolomics with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.
We are thankful to all our speakers for encouraging and supporting us to conduct the conference and catapulting the same to pinnacle of success.
The Organizing Committee would like to thank the moderators Dr Vladimir Tolstikov, BERG, USA and Dr. Matthew E Merritt, University of Florida, USA for their contributions which resulted in smooth functioning of the conference.
A series of invited lectures by Honorable guests and members of the Keynote Forum marked the commencement of the event. Prominent scientists like C Thomas Caskey from Baylor College of Medicine, USA; David A Boothman from University of Texas Southwestern Medical Center, USA; Apostolos Pappas from Johnson & Johnson, Consumer Inc., USA; Dongliang Ge from Nanjing BioSciKin Co. Ltd, China; Vladimir Tolstikov from BERG, USA; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.
Conference Series LLC is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artifact.
We also express our sincere thanks to all the media partners for the promotion of our event to glory.
The best poster presentations were awarded by Dr. Björn Riefke Bayer Pharma AG, Germany to:
Erlong Zhang, Third Military Medical University, China
Conference Series LLC, on behalf of the conference, congratulates the Best poster awardees for their outstanding performance in the field of Metabolomics and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.
Conference Series LLC 7th International Conference and Expo on Metabolomics would coordination of the Journal of Metabolomics: Open Access, Journal of Computer Science and Systems Biology; hence, we express our deep sense of gratitude.
After the successful completion of seven consecutive conferences we are glad to announce our next upcoming conferences which is going to be held in Singapore and USA are,
“8th International Conference and Exhibition on Metabolomics” which is going to be held during May 11-13, 2017 in Singapore.
“10th International Conference and Exhibition on Metabolomics & Systems Biology” which is going to be held during October 19-20, 2017 in Baltimore, USA
Mark your calendars; we are hoping to see you soon!
Past Reports Proceedings Gallery Metabolomics-2015
Past Reports Proceedings Gallery Metabolomics-2014
Past Reports Gallery Metabolomics-2013
Past Reports Gallery